Comparison of Bivalent and Monovalent mRNA Vaccine Boosters.
Wong, CK
; Lau, KT; Au, IC; Lau, EH; Cowling, BJ and
(2023)
Comparison of Bivalent and Monovalent mRNA Vaccine Boosters.
Clinical infectious diseases, 78 (3).
pp. 633-636.
ISSN 1058-4838
DOI: 10.1093/cid/ciad519
; Lau, KT; Au, IC; Lau, EH; Cowling, BJ and
(2023)
Comparison of Bivalent and Monovalent mRNA Vaccine Boosters.
Clinical infectious diseases, 78 (3).
pp. 633-636.
ISSN 1058-4838
DOI: 10.1093/cid/ciad519
In this cohort study conducted in Hong Kong where both bivalent and monovalent formulations of BNT162b2 were available, there were no significant differences in the mortality or hospitalization between those who received bivalent and monovalent mRNA as second boosters. Bivalent and monovalent mRNA boosters appear equally protective against clinical outcomes.
-
picture_as_pdf - Wong-etal-2023-Comparison-of-bivalent-and-monovalent.pdf
-
subject - Accepted Version
-
error - This is an author accepted manuscript version of an article accepted for publication, and following peer review. Please be aware that minor differences may exist between this version and the final version if you wish to cite from it.
-
- Available under Creative Commons: Attribution-NonCommercial-No Derivative Works 4.0
Downloads